Ozempic, the celebrated medication known for managing diabetes and aiding weight loss, is set to launch in generic form soon in India, China, and Canada-offering a promising path to more affordable access as global demand skyrockets, reports The New York Times
Generic Ozempic is set to revolutionize access for billions worldwide, making this breakthrough diabetes and weight management medication more affordable than ever. Experts foresee a game-changing shift in how treatments are delivered and priced across the globe
China is targeting the globe’s most expensive drugs with a bold mission: to dramatically cut costs and make life-saving treatments accessible to more patients. This ambitious move is shaking up the global pharmaceutical scene, transforming pricing strategies and sparking fresh waves of innovation throughout the industry
Following the UK’s decision to slash drug prices, the White House is urging other nations to increase payments to pharmaceutical companies, aiming to find the ideal balance between fueling innovation and guaranteeing global access to essential medicines, officials reveal
Advocacy groups are urging regulators to launch a bold anticompetition probe into Big Pharma’s moves after Brexit, accusing the industry of manipulating the market and driving prices sky-high. This call highlights growing concerns over pharmaceutical practices in the evolving post-Brexit landscape
UK Trade Secretary has launched a fierce critique of the pharmaceutical industry amid heated price negotiations, highlighting soaring drug costs and demanding fairer pricing as critical trade talks loom
Indian pharma stocks plunged sharply following President Trump’s announcement of new drug tariffs. However, analysts urge investors not to panic, highlighting that this sell-off is largely sentiment-driven and the sector’s strong fundamentals remain intact despite the market turbulence
Eli Lilly has temporarily paused UK orders of its diabetes medication Mounjaro ahead of an upcoming price hike, aiming to prevent potential stockpiling. This move carefully manages supply to meet rising demand while preparing for the new pricing structure
Brazil’s groundbreaking update to drug pricing regulations is shaking up the pharmaceutical landscape! Companies are now required to present stronger evidence showcasing their products’ effectiveness and cost-efficiency. This pivotal change could transform market dynamics and enhance access to vital medications throughout the country.
